Market Cap 248.07M
Revenue (ttm) 8.18M
Net Income (ttm) -5.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -61.98%
Debt to Equity Ratio 0.02
Volume 900
Avg Vol 1,226
Day's Range N/A - N/A
Shares Out 47.71M
Stochastic %K 69%
Beta 1.28
Analysts Strong Buy
Price Target N/A

Company Profile

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It also involved in...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 8532 2700
Fax: 61 3 9510 5955
Address:
4-6 Southampton Crescent, Abbotsford, Australia
Latest News on SPHRY
No data available.